Unibest

Pharmaceutical intermediates

Ixazomib Citrate Intermediates

2 pharmaceutical intermediates for Ixazomib Citrate. Indication: Multiple Myeloma.

提交项目All intermediates

About Ixazomib Citrate

Originator
Millennium Pharmaceuticals Inc
Indication
Multiple Myeloma

Available intermediates

2 intermediates currently listed for Ixazomib Citrate. Request specifications, documentation or a quotation for any item below.

Ixazomib Citrate intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate179324-87-9//
CHEMBRDG-BB 7959525667403-46-5//

Other programs under I

Ibrutinib/ Zanubrutinib IguratimodImatinibImeglimin hydrochlorideIndacaterol MaleateInfigratinibIpatacopan HydrochlorideIpragliflozin

Building toward Ixazomib Citrate?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →